Praised for its ‘creativity’ and ’great’ expertise, the team at HBC Avocats maintains a strong reputation for its capabilities in the negotiation and structuring of the full spectrum of transactions; the group regularly assists clients with contract manufacturing, technology transfer, and clinical trial agreements. Practice co-head Jonathan Burnham primarily advises life sciences companies on the drafting and negotiation of commercial agreements, and is praised for his ‘very strong’ expertise. Erwan Cossé is known for his vast knowledge of M&A and venture capital-related issues, assisting a number of biotech clients.
Testimonials
Collated independently by Legal 500 research team.
‘Very in-depth knowledge of the life sciences sector, ability to negotiate and draft contracts.’
‘Jonathan Burnham is educational, efficient and able to move forward quickly on complex contract markups. Fabrice Herbin has excellent knowledge of the CRO and clinical studies sector. The team is an expert in its field, capable of moving forward quickly and efficiently at a very reasonable cost compared to large structures.’
‘Jonathan Burnham has very strong expertise in contractual matters and intellectual property linked to life sciences. Very technical and specific area of expertise in which Jonathan has shown perfect knowledge and mastery.’
‘The specialism of HBC Avocats is both the creativity of the solutions provided, strategic advice as close as possible to the client, and great expertise in the field of life sciences.’
‘The complementarity of Erwan Cossé on corporate law issues and Jonathan Burnham on business development is exemplary. ’
‘Competent and responsive lawyers, understand the client's needs, listen and take our needs into account, and make innovative proposals.’
‘Very good knowledge of the field of biotechnology and health and the constraints of small structures. Agility of the team in their ability to understand the client's legal problems and find the right solutions.’
‘Erwan Cossé - creativity, solution-oriented spirit, speed, agility of mind, and availability.’
Key clients
- Inotrem
- Sanofi
- Pierre Fabre
- Emergence Therapeutics
- Onward Therapeutics
- OSE Immunotherapeutics
- Theranexus
- Novasep / Axplora
- Vital Meat
- Kyron.bio
- Nuntius Therapeutics
- Global Antibiotic Research and Development Partnership
- Inserm Transfert
- Biophytis
- Memo Therapeutics
- Aleva Neurotherapeutics
- Eligo Bioscience
- Urosphere
- BliNK Biomedical
- InFlectis BioScience
- Perha Pharmaceuticals
- OT4B
- Xentech
- WatchFrog
- Austral DX
- Axess Vision Technology
- Backbone
- Esprimed
- Geonomy
- Luxia Scientific
- Priothera
- STH Biotech
- Stimunity
- M CAPITAL
- IRDI CAPITAL INVESTISSEMENT
Work highlights
- Advised Emergence Therapeutics, a French and German biotech company, on the drafting and negotiating of a license agreement to obtain access to the Dutch biotech company Synaffix’s proprietary antibody drug conjugate (ADC) technology platform for use with ADC products developed by Emergence.
- Advised Memo Therapeutics AG, a Swiss biotech company specialised in antibody discovery, on the structuring, drafting and negotiation of a research and development collaboration and license agreement with the Japanese pharmaceutical company Ono Pharmaceutical, aimed at discovering, validating and developing antibodies in the field of immuno-oncology.
- Advised ESPRIMED, a French company specialized in medical physics and radioprotection, on the structuring, drafting and negotiation of the acquisition of SANTOPTA, a French company specialised in imaging organization consulting, in order to better support medical imaging and nuclear medicine.
Lawyers
Practice head
The lawyer(s) leading their teams.
Jonathan Burnham, Erwan Cossé